World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
46
Citations
7920
World Ranking
4909
National Ranking
1898

Best Publications

  • Coccidioidomycosis

    Unknown

  • 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis

    John N. Galgiani;Neil M. Ampel;Janis E. Blair;Antonino Catanzaro

  • Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.

    Michael J. Joyner;Rickey E. Carter;Jonathon W. Senefeld;Stephen A. Klassen

  • Early safety indicators of COVID-19 convalescent plasma in 5000 patients.

    Michael J. Joyner;R. Scott Wright;Delisa Fairweather;Jonathon W. Senefeld

  • Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients.

    Michael J. Joyner;Katelyn A. Bruno;Stephen A. Klassen;Katie L. Kunze

  • Early Outpatient Treatment for Covid-19 with Convalescent Plasma

    Unknown

  • Coccidioidomycosis in Solid Organ Transplantation

    Unknown

  • Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts.

    Unknown

  • Donor-derived fungal infections in organ transplant recipients: Guidelines of the American society of transplantation, infectious diseases community of practice

    N. Singh;S. Huprikar;S. D. Burdette;M. I. Morris

  • Voriconazole Use for Endemic Fungal Infections

    Alison Gail Freifeld;Laurie Proia;David Andes;Larry M. Baddour

  • Coccidioidomycosis

    Unknown

  • The Cephalosporins

    Unknown

  • A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation.

    Walter C. Hellinger;Joseph D. Yao;Salvador Alvarez;Janis E. Blair

  • Opportunistic infections in patients with pulmonary alveolar proteinosis

    Unknown

  • Executive Summary: 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis

    John N. Galgiani;Neil M. Ampel;Janis E. Blair;Antonino Catanzaro

  • Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study

    Unknown

  • Treatment of Refractory Coccidioidomycosis With Voriconazole or Posaconazole

    Unknown

  • Coccidioidal Pneumonia, Phoenix, Arizona, USA, 2000–2004

    Unknown

  • Coccidioidomycosis in Patients with Diabetes Mellitus

    Unknown

  • Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients.

    Michael Joyner;R Scott Wright;DeLisa Fairweather;Jonathon Senefeld

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Recently Published Articles